|
NAVIGATION
|
 |
|
Publications
Stockholm Network publications span a range of topics including European healthcare reform, corporate social responsibility, counterfeit pharmaceuticals, environmental issues and social security. If you would like to order a hard copy of any of these publications, please email Paul Healy.
|
|
|
|
Eye On Europe 5
by Stockholm Network (published 2005)
The Stockholm Network discusses the future of health care in Europe, polling eight of the EU countries on issues of sustainabilty and reform. The Paradox of Choice by Barry Schwartz is reviewed.
|
|
|
|
Know IP: Volume 1 - Issue 5
by Stockholm Network (published 2005)
In this issue of Know IP the authors look at the following issues: 1) IP Debates Throughout History 2) Market Leaders and Industrial Policy 3) Humane Gene Patenting
|
|
|
|
Know IP: Volume 1 - Issue 4
by Stockholm Network (published 2005)
In this issue of Know IP the following issues are addressed: 1) European Patent Harmonisation 2) New Technology- Based Firms 3) Pharmaceutical IPRs in Europe
|
|
|
|
Eye On Europe 4
by Stockholm Network (published 2005)
In this issue of the Stockholm Network`s quarterly newsletter, Ukraine`s allegedly tainted elections are examined, member think tanks are profiled and James Surowiecki`s book The Wisdom of Crowds is reviewed.
|
|
|
|
Know IP: Volume 1 - Issue 3
by Stockholm Network (published 2005)
In the third issue of Know IP the following topics are covered: 1) Software Patents in Europe 2) WTO GIs Dispute 3) IP, Generics and ARV Treatment 4) Singapore`s IP Regime
|
|
|
|
Know IP: Volume 1 - Issue 2
by Stockholm Network (published 2005)
In this issue of Know IP the authors analyse the following issues: 1) Licensing, Developing Countries and IPRs 2) Design Protection and European Competitiveness 3) Bilateral Free Trade Agreements
|
|
|
|
State of the Union
by Sacha Kumaria (ed.) (published 2005)
A report by the Stockholm Network, The State of the Union, examines the progress of market-oriented reform in the EU member states, and at EU level, in 2004. Thirty authors contributed to this study, which seeks to understand the unique set of historical, cultural and social circumstances that have obstructed the path to reform in individual member states over the past twelve months. These national differences have been at the core of the European Union’s failure to implement its Lisbon Agenda, for while the EU is publicly committed to reform, it is institutionally opposed to it. And while José Manuel Barroso’s Presidency of the European Union constitutes an unprecedented opportunity for economic reform in Europe, most of the true burden for reform lies with the member states. The state of the union in 2005 and beyond will depend less on Brussels, and more on the sum of its parts.
|
|
|
|
Know IP: Volume 1 - Issue 1
by Stockholm Network (published 2005)
In the first ever issue of Know IP, the following issues are addressed: 1) The New Stockholm Network IP and Competition Programme 2) Microsoft and the Compulsory Licensing of IP 3) India`s New Patent Ordinance
|
|
|
|
Eye On Europe 3
by Stockholm Network (published 2005)
Questioning the heavy-handedness of the British government, SN argues that concerns for public welfare may have taken on a Big Brother approach. This issue also reviews Global Crises, Global Solutions by Bjorn Lomborg who asks: how can money be most efficiently spent in solving the ten greatest challenges facing the earth today?
|
|
|
|
A Sick Business
by Graham Satchwell (published 2004)
ISBN: 0-9547663-2-6
Recent decades have seen an astounding change in the way we view healthcare. Medical innovation has brought new treatments for all sorts of diseases. But there is a dark side to the growth in demand for medicines. Counterfeiting of pharmaceuticals is now a global trade. Conducted by a former policeman, this investigation into the trade in fake medicines and its links with organised crime uncovers a horrifying story. Across Europe, counterfeiters have discovered a range of easy routes for selling fake and sub-standard products into the legitimate distribution chain. A Sick Business shows how, to the uninitiated eye, this crime is invisible. Most patients and consumers are unaware just how many public safety problems counterfeit medicines may cause. It argues that this illegal business is conducted by unscrupulous people whose actions have already cost thousands of lives and may even be linked to terrorist activity – yet almost nothing is being done to stop it.
|
|
|
|
|